Biologics Quality Assurance and Regulatory Affairs
Global regulatory compliance and quality assurance built into every biologics process, every product, every time
Experience with global regulators
Proven expertise with global regulators, including EMA, FDA and ANVISA, ensuring compliance at every stage
Quality assurance
Quality oversight tailored to the product life cycle
Regulatory success
Proven track record with INDs, IMPDs, BLAs, and MAAs
“From the outset, we meet the US FDA and EMA standards, embedding data integrity into every step.”
When gaps create risk
- Poor understanding of regional regulations
- Documentation that fails scrutiny during inspections
- Late-stage issues requiring costly fixes
- Uncertainty in filings and timelines
Confidence built into every stage
- Market-specific regulatory expertise and strategies
- Consistent, defensible data and filings
- Early QA integration to prevent late surprises
- Smooth, predictable inspections and approvals
Phase-appropriate quality systems and global biologics regulatory expertise
Integrated QA and regulatory strategies for faster approvals and smoother inspections.
Phase-appropriate QA
QA strategies scale with each phase-lean early, robust later-driving smooth progression, faster decisions, and quality filings while avoiding early over-engineering and late-stage gaps
Global regulatory expertise
Our expertise with proven experience working alongside EMA, FDA, ANVISA, and other global regulators, we deliver market-ready filings, enabling faster approvals, fewer surprises, and lower risk of delays or remediation
Embedded quality systems
Built-in quality and harmonized systems reduce deviations, streamline inspections, and build confidence with regulators, investors, and partners
GMP oversight, CMC filings, and inspection readiness for biologics
Our biologics quality and regulatory teams work proactively to prevent issues before they arise, ensuring your program moves forward with confidence
Quality Services
Services that speed progress and reduce risk
- QA oversight from development to commercial
- Batch record design, review, and approval
- Deviation management and CAPA programs
- Change control coordination
- QA support during tech transfer and PPQ
- Governance and quality risk assessments
- Full integration with MSAT, regulatory, and manufacturing QA
Regulatory Services
End-to-end regulatory support
- High-quality, consistent Module 3 and CMC data
- Client and regulatory audit hosting
- Inspection readiness planning
- Support for RFIs, Q&A, variations, and escalations
Where dedication
delivers capabilities
End-to-end European biologics CDMO services, from QA oversight to regulatory filings, deliver “ready to fill” products faster, at lower cost, with greater compliance confidence
Process development & characterization
Scalable upstream and downstream processes built for robustness
Read more
Analytical capabilities
Phase-appropriate, method-qualified testing for product quality and release
Read more
GMP manufacturing
Flexible capacity and inspection-ready operations for biologics production
Read more
Why biotechs and pharmaceuticals
choose Rezon Bio
We combine the scale of an established European CDMO with the agility of a focused partner, backed by 0 critical audit findings and proven regulatory expertise across multiple markets globally, including FDA, EMA and ANVISA
Transparent. Clear. Reliable.
Partner with a European biologics CDMO built for your program
- Whether you’re advancing a novel biologic or planning for commercial scale, Rezon Bio is ready to help you move forward with confidence
- Connect with our team to explore how our expertise, integrated solutions, and dedication can accelerate your success